He mentioned, "There hasn't been a notable opposition from our members in challenging these items, possibly because they don't meet the criteria under 503A." According to Section 503A of the Food, Drug & Cosmetic Act, an eligible bulk drug substance for compounding must be a component of an FDA-approved drug, must have a USP or NF monograph, or must appear on the FDAs 503A Bulks List or Interim Bulks List Category 1
This may also have a dramatic impact on overall joint and muscle health
The fungal chitosan (an amino polysaccharide derived from Fusarium oxysporum ) loaded with bee venom nanoparticles was an effective anti-tumor agent for cervix carcinoma (HeLa cells) (211)
Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM
Understanding these possible side effects is a critical step in your decision-making process